Sean D. McKinney

Focus on Artificial Intelligence (AI) to deliver a Software Enabled Ultrasound (SEU) solution that re- defines Ultrasound imaging in a pocket-sized, ultraportable-handheld, whole-body wireless probe for diagnostic care.
• Drive growth and maximize earnings potential by amplifying the brand with traditional customers and advancing the existing horizon with Medicare Administrative Contractors, Commercial and Private Insurers.
• Identified KPIs, services and new customers. Utilized data to devise innovative sales and marketing plans enabling dramatic growth.
• Produced detailed and relevant reports for consideration in making select business decisions.
• Analyzed the scope of current, as well prospective, procedural coding and reimbursement aspects.
• Developed multi-market access strategies and vetted distributor networks.

Orchestrated a comprehensive market analysis of the Cardiac Arrhythmia Detection Market. Implemented sales team strategies and KPIs to increase brand awareness within the Cardiology, EP and Sports Medicine disciplines for CARDEA 20/20 ECG and SOLO 7-Day wearable ECG Sensor Technology & Proprietary Software for the detection of serious, often silent, life-threatening arrhythmias.
• Owned all aspects of Sales Planning, Team Development, and Account Management.
• Conducted the Strategic Revenue Growth for CARDEA 20/20 and SOLO with 18 Indirect Representatives and 3 Region Managers across 16 Eastern U.S. States.
• Forecasted Annual Sales of $2M-$3M-$4M and led "Solution-Selling Strategy" initiatives to achieve sales goals for CARDEA 20/20 ECG and SOLO.
• Formulated and presented innovative Strategies to Team members, Executives and Customers to build foundation for successful sales plans. Developed ambitious sales targets, managed deployment strategies, and designed "go-to-market" plans to capitalize on every revenue opportunity.
• Secured strategic relationships with Key Hospitals/IHNs, Cardiologists, Sports Cardiologists, NCAA University Athletic Departments, Professional Sports Teams-NFL-NBA-NHL-MLB, and Youth Advocacy Organizations, resulting in a cohesive and sustainable adoption of Cardiac Insight ECG Technologies.
• Connected with prospective customers through industry trade shows, cold calling and State/Regional Networks, Advocacy Group events and interactions with Community leaders to raise awareness of SCD/SCA in ages 15-32.
• Established a foothold in the Primary Care & Sports Medicine Markets through a National Distributor Network, Henry Schein-Sports Medicine Division.
• Advanced relationships with University Hospitals and Clinical Study entities, as well as industry CROs.
• Grew market penetration and sales figures by leveraging Distributor relationships and personally overseeing negotiations resulting in 150% revenue increase vs. Plan with High Schools, Colleges and Universities.
• Secured renowned Cardiology KOL services for the Cardiac Insight Scientific Advisory Board.
• Resolved issues/problems with high-profile customers to maintain relationships and increase return customer base.

Management Consultant 2015
• Led growth plans and strategies for developing profitable business through Market Access approach, IHDNs and Distributor Networking.
• Developed client retention and growth plan strategies for current business with CAT III Coding and Reimbursement in lieu of prospective CAT I Coding and Reimbursement.
• Identified and managed Payer Relations with Medicare Administrative Contractors, Commercial and Private Insurers.

In Women’s Health - providing an Alternative to Hysterectomy, the Acessa Procedure utilizes RF Ablation for Fibroid Treatment. Served as the Primary Market Access Liaison for Physicians, Staff, Facility and Halt Field Sales Management.
• Spearheaded successful business development initiatives aligned with company's strategy and core competencies.
• Communicated Acessa procedural Economic Value proposition and patient QOL findings to Commercial Payers, Surgeons, Facilities, and C-Suite executives.
• Devised implementation strategies & assisted in Clinical Dossier preparation for Payer Non-Coverage Policies.
• Implemented a “Hospital/ASC Financial Model,” in tandem with the viability of billing for “Non-Routine High-Cost” disposables, to support Acessa Value-Proposition.
• Developed Reimbursement tools to facilitate project initiatives, trainings, and administrative activities.
• Surpassed Surgeon adoption and Procedure Benchmarks in Q3 and Q4. Acessa adoption rates increased by 250% vs. previous year.

Assisted Field Sales Team in educating Surgeons, Hospitals, and Ambulatory Surgery Centers staff on the Economic Value Proposition and QOL enhancements of the iFuse Implant System for Sacroiliac Joint Fusion. Partnered with Field Sales to address Economic Barriers to Surgical Utilization and Adoption of iFuse Implant Technology.
• Formally presented iFuse Clinical, QOL and Economic-Value propositions to Regional Payer Medical Directors.
• Developed and Maintained relationships with Payers through consistent communication paving the way for Medical Policy approvals.
• Conceptualized and implemented the “Hospital/ASC Financial Model,” streamlining dialogue with C-Level Executives and Technology Evaluation Committees (TEC).
• Coordinated “Pre-Auth” Protocols and Reimbursement activities between Physician Offices and 3rd Party Case Management group.
• Recruited Surgeon KOL support for regional Payer meetings.
• Expanded cross-functional organizational capacity by collaborating across departments on priorities, events, and common goals.
• Prepared and recommended Long-Range plans for development of Reimbursement Department personnel.
• Compiled data highlighting Key Metrics to report information, determine trends and identify methods for improving Results.

Additional Experience
Director-Field Reimbursement: ST. FRANCIS MEDICAL TECHNOLOGIES - KYPHON, Alameda, CA
Vice President of Sales: iCARDIA HEALTHCARE CORPORATION, Lake Forest, IL
Director of Sales: CARDIONET, Malvern, PA
Director of Sales: LIFEWATCH, Buffalo Grove, IL